— Know what they know.
Not Investment Advice

BLTE NASDAQ

Belite Bio, Inc
1W: -2.7% 1M: -14.3% 3M: -8.1% YTD: -10.0% 1Y: +55.4% 3Y: +343.1%
$145.72
+2.37 (+1.65%)
After Hours: $148.58 (+2.86, +1.96%)
Weekly Expected Move ±6.0%
$130 $138 $147 $156 $165
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 25 · $5.8B mcap · 20M float · 0.960% daily turnover · Short 64% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' 57.62.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-97M
Net Income
-137.0% YoY
$-22M
Free Cash Flow
+25.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-20.8%
ROA-20.3%
ROIC-11.5%

Valuation

P/E-52.9
P/B7.6
EV/EBITDA-56.9

Leverage

Debt/Equity0.00
Current Ratio33.56
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z248.69
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms